Production (Stage)
Kronos Bio, Inc.
KRON
$0.872
$0.00210.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -17.89% | -4.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.89% | -4.22% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -17.89% | -4.22% | |||
| SG&A Expenses | 8.51% | -13.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.21% | -26.28% | |||
| Operating Income | 42.38% | 29.61% | |||
| Income Before Tax | 67.60% | -82.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 67.60% | -82.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 67.60% | -82.97% | |||
| EBIT | 42.38% | 29.61% | |||
| EBITDA | 42.24% | 30.38% | |||
| EPS Basic | 67.86% | -82.90% | |||
| Normalized Basic EPS | 45.98% | 31.12% | |||
| EPS Diluted | 67.86% | -82.90% | |||
| Normalized Diluted EPS | 45.98% | 31.12% | |||
| Average Basic Shares Outstanding | 0.77% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.77% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||